Venture Capital

Brightlands Venture Partners

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Series A, Series B, Growth, Late Stage

Geographical Focus
Germany, France, Luxembourg, Netherlands, Belgium

Industries Focus

  • Renewable Energy
  • HealthTech
  • FoodTech
  • Life Sciences
  • AgriTech
  • Biotech
  • Medtech
  • Cleantech
  • Circular Economy
  • Regenerative Medicine
  • Environmental Technologies
  • Sustainable Materials
  • Agrifood
  • Renewable Chemistry
  • Biomedical Materials

Investment Size:
250,000 to 2,000,000 USD

Investor Details Founded: 2004

Brightlands Venture Partners is an independent venture capital fund manager based in the south of the Netherlands, focusing on sectors such as renewable chemistry, agrifood, and health. The firm manages four funds with a total committed capital of €120 million: Limburg Ventures (€15 million, founded in 2004), Chemelot Ventures (€40 million, founded in 2014), Brightlands Agrifood Fund (€20 million, founded in 2017), and BVP Fund IV (€45 million, established in April 2021). These funds aim to support innovative companies that contribute to the Brightlands ecosystem, which encompasses campuses in Geleen, Maastricht, Venlo, and Heerlen.

The firm's investment strategy targets early to late-stage companies with breakthrough proprietary technologies and strong growth ambitions. Brightlands Venture Partners seeks to invest in companies with top-notch teams and credible business models, focusing on sectors such as renewable chemistry, agrifood, health, and related digital technologies. The firm typically invests between €250,000 and €2 million per company, with an exit horizon of less than seven years.

Brightlands Venture Partners emphasizes active support for its portfolio companies by leveraging deep sector expertise and a vast network. The firm can assume the role of lead investor and reserves significant amounts for follow-on investments to support companies in future funding rounds. This approach aims to accelerate sustainable businesses that address major environmental and health challenges, contributing to the growth and success of the Brightlands ecosystem.

Requirements
  • Top-notch team
  • Breakthrough proprietary technology
  • Strong growth ambition
  • Credible business model
  • Exit horizon < 7 years
  • Seed – Series A stage
  • €250k – €2M initial ticket size
  • Based in Europe
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Psylaris
  • Novenda Technologies
  • Vivalyx
  • Greencovery
  • S&dB
  • Pectcof
  • Fuenix
  • Neuroplast
  • Vacis
  • Pharmalot
  • Kriya Materials
  • Fortimedix Surgical
Claim this Investor

Are you an official representative of Brightlands Venture Partners?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim